Y-Intercept (HK)’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$112K Buy
+30,657
New +$112K ﹤0.01% 1525
2024
Q2
Sell
-140,925
Closed -$258K 1349
2024
Q1
$258K Buy
+140,925
New +$258K 0.02% 1033
2022
Q3
Sell
-25,303
Closed -$9K 934
2022
Q2
$9K Buy
+25,303
New +$9K ﹤0.01% 816